- CG Oncology (NASDAQ:CGON) priced its public providing of 8M shares of its frequent inventory, of which 7.3M is obtainable by the corporate and 700,000 by present shareholders at an providing value of $28.00 per share.
- The gross proceeds are anticipated to be $204.4M.
